NCT01911780 - Compare Efficacy and Safety of Telmisartan/Hydrochlorothiazide With Telmisartan/Hydrochlorothiazide Plus Amlodipine | Biotech Hunter

Enrollment

132

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions

Hypertension

Interventions

DRUG

placebo

placebo matching amlodipine capsule

DRUG

telmisartan + HCTZ

FDC tablet

DRUG

telmisartan + HCTZ

FDC tablet

DRUG

amlodipine

capsule

Trial Locations (17)

1348.2.020 Boehringer Ingelheim Investigational Site, Chiyoda-ku, Tokyo

1348.2.008 Boehringer Ingelheim Investigational Site, Chuo-ku, Fukuoka, Fukuoka

1348.2.018 Boehringer Ingelheim Investigational Site, Chuo-ku,Kobe, Hyogo

1348.2.006 Boehringer Ingelheim Investigational Site, Chuo-ku,Tokyo

1348.2.013 Boehringer Ingelheim Investigational Site, Chuo-ku,Tokyo

1348.2.021 Boehringer Ingelheim Investigational Site, Chuo-ku,Tokyo

1348.2.012 Boehringer Ingelheim Investigational Site, Hirakata, Osaka

1348.2.011 Boehringer Ingelheim Investigational Site, Kasaoka, Okayama

1348.2.001 Boehringer Ingelheim Investigational Site, Kawasaki, Kanagawa

1348.2.019 Boehringer Ingelheim Investigational Site, Kita-ku, Osaka-shi, Osaka

1348.2.014 Boehringer Ingelheim Investigational Site, Kiyota-ku, Sapporo-shi, Hokkaido

1348.2.002 Boehringer Ingelheim Investigational Site, Kumamoto, Kumamoto

1348.2.007 Boehringer Ingelheim Investigational Site, Nakano-ku,Tokyo

1348.2.009 Boehringer Ingelheim Investigational Site, Nishi-ku, Fukuoka, Fukuoka

1348.2.005 Boehringer Ingelheim Investigational Site, Takatsuki, Osaka

1348.2.016 Boehringer Ingelheim Investigational Site, Uji, Kyoto

1348.2.010 Boehringer Ingelheim Investigational Site, Yoshikawa, Saitama